Holo-Blister® awarded patents in both the U.S. and Europe

Pharmaceutical

Holographyx Inc. is pleased to announce that it has recently been granted a U.S. patent for its Holo-Blister® product along with a European Patent for the development of this unique and cost-effective method to apply holograms to the back of blister packs using conventional heat-seal blister packaging equipment. Holo-Blister® holograms have been designed so that they will only be visible behind each pill/capsule cavity on the back of each blister pack, thereby allowing the printing of dosage and marketing information on the area surrounding the pill/capsule recess.

The size of the worldwide market for counterfeit pharmaceuticals has been estimated to be as much as $200 billion annually. Although anti-counterfeiting measures such as "track and trace" can be used to distinguish legitimate pharmaceutical products from counterfeits, these systems require consumers to go on-line to validate each of their pharmaceutical purchases. Blister-packaging utilizing Holo-Blister® provides consumers with the ability to visually validate the authenticity of their purchases instantly with the use of custom holograms that, prior to the development of Holo-Blister®, would be extremely difficult to manufacture and apply.

“Holo-Blister® is a new anti-counterfeiting system for pharmaceutical blister-packs that has just been awarded patents in both the U.S. and Europe.“

Holographyx Inc. has been working with the Hazen Paper Company in cooperation with Uhlmann Packaging on the development, testing, and introduction of Holo-Blister®.

See all the latest jobs in Pharmaceutical
Return to news